News Release from Neuromics RNAi Collaborators

Alnylam - Developing Technology With Gene Silencing Potential
... of Dr. Frank Porreca and Dr. Josephine Lai at the University of Arizona
evaluated siRNAs that target the gene for NPY, a pain-associated peptide. ...

Annual SFN Chicago Meeting-March 3rd 2006

The meeting will be held at the Harold Washington Library in downtown Chicago.

We are pleased that Dr Tomas Hokfelt, a friend and key Neuromics' collaborator, will be presenting:

Three Decades of with Three Swedish Peptides: Substance P, NPY and Galanin

“Working with Neuromics has truly been a collaborative effort, from the initial antibody generation strategy to its development and characterization. This interaction between our groups was an important factor in our successful generation of a novel NPY Y2 antibody.” Dr. Tomas Hokfelt, Karolinska Institute

More specifics to follow...

PDF to Walter Low's Stem Cell Data

Here's the Link

Walt Low's PDF Report on Neuromics' Rat NSCs

Neural Stem Cell Data Was Generated Using Neuromics' Neural Stem Cell Kit (Cat#: NP37100)

New Antibody from The David Holtzman Lab

ABCA1

By Western blot mouse anti-ABCA1 (MO13101; clone HJ1) recognizes rat (left image), mouse (right image) and to a lesser extent human (left image) ABCA1.

Dr. David Holtman Lab-Washington University School of Medicine

http://www.neuro.wustl.edu/people/holtzman.html